S Potoczek

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.

Tadeusz Robak, Marek Kasznicki, Maria Błasińska-Morawiec et al. · PubMed · 2000 · 221 citations

Medicine, Oncology, Pharmacology +11

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor et al. · Journal of Clinical Oncology · 2010 · 99 citations · Full text

Medicine, Oncology, Pharmacology +16

2‐Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7‐year experience in Poland

Tadeusz Robak, Maria Błasińska-Morawiec, J. Błasiński et al. · European Journal Of Haematology · 1999 · 82 citations

Medicine, Hematology, Oncology +8

The soluble CTLA-4 receptor: a new marker in autoimmune diseases.

Edyta Pawlak, Iwona Kochanowska, Irena Frydecka et al. · PubMed · 2005 · 43 citations

Life Sciences, Immunology, Autoimmunity +15

Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population

Lidia Karabon, Edyta Pawlak, Anna Tomkiewicz et al. · Pathology & Oncology Research · 2011 · 33 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16